How to Get Crysvita (Burosumab) Covered by Humana in Illinois: Appeal Templates and Approval Guide
Quick Answer: Getting Crysvita (Burosumab) Approved by Humana in Illinois
Prior authorization is required. Humana requires genetic confirmation of X-linked hypophosphatemia (XLH) or documented tumor-induced osteomalacia (TIO), evidence of failed conventional therapy, and specialist oversight. If denied, you have 65 days to appeal internally, then 4 months for Illinois external